The need to improve clinical trial set-up processes in order to reduce timelines and increase patients’ access to research has been consistently on the UK life sciences agenda for several years. It has also been highlighted as an area of importance in conversations between the Association of British Pharmaceutical Industries (ABPI), Shelford Group Chief Executive and Medical Directors, and UKRD – R&D leaders in the NHS (UKRD).
In response, the three organisations convened a working group of senior NHS R&D leaders and pharmaceutical company representatives to help achieve a common understanding of where the main challenges are, and how they can be addressed. This has led to the development of a best practice guide aimed at helping to improve clinical trial set-up processes in the UK. The guide covers the following four areas:
- Establishing a study’s feasibility
- Confirming a site’s capability and capacity
- Escalating blockers to study set-up and delivery
- Establishing strategic communication between sites and sponsors
Click here to read and download the publication.